Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (461-470 of 544) with videos related to

Pageof 55
Sort By:
Vaccine|January 27, 2004
Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentationEdward Rothstein, Katrin S Kohl, Leslie Ball, et al.
Vaccines|December 23, 2022
Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis InitiativeBahaa Abu-Raya, Kevin Forsyth, Scott A Halperin, et al.
Vaccine|January 23, 2026
Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trialsJoanne M Langley, Manish Sadarangani, Christian Ockenhouse, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
The Journal of Infection|February 15, 2026
Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, CanadaSelma Osman, Michelle Science, Elizabeth McLachlan, et al.
Pediatrics|September 5, 2006
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004Dorothy L Moore, Wendy Vaudry, David W Scheifele, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
Oncotarget|September 1, 2012
Tumor suppression by small molecule inhibitors of translation initiationLimo Chen, Bertal H Aktas, Yibo Wang, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|March 25, 2020
Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significanceJennifer E Isenor, Melissa S Kervin, Donna M Halperin, et al.
Journal of the American Chemical Society|March 29, 2007
Ultrahigh-resolution (1)H-(13)C HSQC spectra of metabolite mixtures using nonlinear sampling and forward maximum entropy reconstructionSven G Hyberts, Gregory J Heffron, Nestor G Tarragona, et al.
Pageof 55

Showing results (461-470 of 544) with videos related to

Sort By:
Pageof 55
Vaccine|January 27, 2004
Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentationEdward Rothstein, Katrin S Kohl, Leslie Ball, et al.
Vaccines|December 23, 2022
Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis InitiativeBahaa Abu-Raya, Kevin Forsyth, Scott A Halperin, et al.
Vaccine|January 23, 2026
Safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive healthy adults: Results from 2 randomised, controlled clinical trialsJoanne M Langley, Manish Sadarangani, Christian Ockenhouse, et al.
Vaccine|March 6, 2018
Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised studyClare L Cutland, Terry Nolan, Scott A Halperin, et al.
The Journal of Infection|February 15, 2026
Assessing measles immunity in individuals of childbearing age in Toronto, Ontario, CanadaSelma Osman, Michelle Science, Elizabeth McLachlan, et al.
Pediatrics|September 5, 2006
Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004Dorothy L Moore, Wendy Vaudry, David W Scheifele, et al.
Human Vaccines & Immunotherapeutics|June 10, 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trialGlenn Hamonic, Supriya Arora, Ravendra Garg, et al.
Oncotarget|September 1, 2012
Tumor suppression by small molecule inhibitors of translation initiationLimo Chen, Bertal H Aktas, Yibo Wang, et al.
Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC|March 25, 2020
Pharmacists as immunizers to Improve coverage and provider/recipient satisfaction: A prospective, Controlled Community Embedded Study with vaccineS with low coverage rates (the Improve ACCESS Study): Study summary and anticipated significanceJennifer E Isenor, Melissa S Kervin, Donna M Halperin, et al.
Journal of the American Chemical Society|March 29, 2007
Ultrahigh-resolution (1)H-(13)C HSQC spectra of metabolite mixtures using nonlinear sampling and forward maximum entropy reconstructionSven G Hyberts, Gregory J Heffron, Nestor G Tarragona, et al.
Pageof 55